ExploRNA’s proprietary technology

ExPLoRNA Therapeutics presents a family of compounds inspired by biology.
Our vast library of cap analogs offers unprecedented opportunity to create tailor made mRNA for vaccines and therapeutics products.

Our two lead products are ExploCap® and AvantCap®.

AvantCap Q1 Delivers high yields and capping efficiencies across a wide range of IVT conditions


-> Compare to other cap analogs
AvantCap Q2 Delivers Cap 2 modification with high yields and capping efficiencies across a wide range of IVT conditions

-> Compare to other cap analogs
AvantCap AG High yields and capping efficiencies



-> Compare to other cap analogs
ExploCap Delivers high IVT yields and capping efficiencies



-> Compare to other cap analogs
Learn more about
science & technology

Cart 0

Your cart is empty. Continue shopping and see what special awaits you!